Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Marston Linehan

Showing results (461-470 of 487) with videos related to

Pageof 49
Sort By:
American Journal of Human Genetics|August 21, 2018
Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing PilotJulie C Sapp, Jennifer J Johnston, Kate Driscoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumorsMichael L Nickerson, Erich Jaeger, Yangu Shi, et al.
Nature Communications|August 23, 2024
Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and BenchmarkLuopin Wang, Aryamav Pattnaik, Subhransu Sekhar Sahoo, et al.
Clinical Genitourinary Cancer|October 6, 2018
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary CarcinomaPavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.
The American Journal of Pathology|February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studiesJohn W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
Molecular Cancer Research : MCR|May 3, 2019
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human DiseaseMasaya Baba, Mitsuko Furuya, Takanobu Motoshima, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Impaired oxidative phosphorylation drives primary tumor escape and metastasisEmily N Arner, Erin Q Jennings, Daniel R Crooks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
European Urology|January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer TypesAxel Bex, Michael Jewett, Bryan Lewis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2024
Toward a CRISPR-based mouse model of <i>Vhl</i>-deficient clear cell kidney cancer: Initial experience and lessons learnedLaura A Stransky, Wenhua Gao, Laura S Schmidt, et al.
Pageof 49

Showing results (461-470 of 487) with videos related to

Sort By:
Pageof 49
American Journal of Human Genetics|August 21, 2018
Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing PilotJulie C Sapp, Jennifer J Johnston, Kate Driscoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumorsMichael L Nickerson, Erich Jaeger, Yangu Shi, et al.
Nature Communications|August 23, 2024
Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and BenchmarkLuopin Wang, Aryamav Pattnaik, Subhransu Sekhar Sahoo, et al.
Clinical Genitourinary Cancer|October 6, 2018
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary CarcinomaPavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.
The American Journal of Pathology|February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studiesJohn W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
Molecular Cancer Research : MCR|May 3, 2019
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human DiseaseMasaya Baba, Mitsuko Furuya, Takanobu Motoshima, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Impaired oxidative phosphorylation drives primary tumor escape and metastasisEmily N Arner, Erin Q Jennings, Daniel R Crooks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
European Urology|January 24, 2025
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer TypesAxel Bex, Michael Jewett, Bryan Lewis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2024
Toward a CRISPR-based mouse model of <i>Vhl</i>-deficient clear cell kidney cancer: Initial experience and lessons learnedLaura A Stransky, Wenhua Gao, Laura S Schmidt, et al.
Pageof 49